C
Claus Kristensen
Researcher at University of Copenhagen
Publications - 105
Citations - 3321
Claus Kristensen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Head and neck cancer & DAHANCA. The author has an hindex of 27, co-authored 95 publications receiving 2914 citations. Previous affiliations of Claus Kristensen include Novo Nordisk.
Papers
More filters
Journal ArticleDOI
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.
Peter Kurtzhals,Lauge Schäffer,Anders Robert Sorensen,Claus Kristensen,Ib Jonassen,Christoph Schmid,Thomas Trüb +6 more
TL;DR: The combination of the B31B32diArg and A21Gly substitutions provided insulin glargine with a 6- to 8-fold increased IGF-I receptor affinity and mitogenic potency compared with human insulin, and the reduced in vitro potency of insulin detemir might explain why this analog is not as effective on a molar basis as human insulin in humans.
Journal ArticleDOI
Alanine Scanning Mutagenesis of Insulin
Claus Kristensen,Thomas Kjeldsen,Finn C. Wiberg,Lauge Schäffer,Morten Hach,Svend Havelund,Joseph Bass,Donald F. Steiner,Asser Sloth Andersen +8 more
TL;DR: The most striking finding is that B20Ala insulin retains high affinity binding to the receptor, and replacing GlyB20 with alanine most likely modifies the structure of the B-chain in this region, but this structural change appears to enhance binding toThe insulin receptor.
Journal ArticleDOI
Engineered CHO cells for production of diverse, homogeneous glycoproteins.
Zhang Yang,Shengjun Wang,Adnan Halim,Morten Alder Schulz,Morten Frödin,Shamim Herbert Rahman,Malene Bech Vester-Christensen,Malene Bech Vester-Christensen,Carsten Behrens,Claus Kristensen,Sergey Y. Vakhrushev,Eric P. Bennett,Hans H. Wandall,Henrik Clausen +13 more
TL;DR: An engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential by constructing a design matrix that facilitates the generation of desired glycosylation, such as human-like α2,6-linked sialic acid capping.
Journal ArticleDOI
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
Pernille Lassen,Hanne Primdahl,Jørgen Johansen,Claus Kristensen,Elo Andersen,Lisbeth Juhler Andersen,Jan F. Evensen,Jesper Grau Eriksen,Jens Overgaard +8 more
TL;DR: The independent influence of HPV-associated p16-expression in advanced OPC treated with primary RT was confirmed, however, RT-outcome in the group of non-OPC did not differ by tumor p 16-status, indicating that the prognostic impact may be restricted to OPC only.
Journal ArticleDOI
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake
A.K. Due,Ivan R. Vogelius,Marianne C. Aznar,Søren M. Bentzen,Anne Kiil Berthelsen,Stine Korreman,Annika Loft,Claus Kristensen,Lena Specht +8 more
TL;DR: The detailed pattern-of-failure data analysis suggests that most recurrences occur in the FDG PET positive areas or the solid tumor.